INTERNATIONAL PATENT: Q32 BIO INC. FILES APPLICATION FOR "TARGETED TREATMENT OF COMPLEMENT-MEDIATED DISEASE THROUGH LOCAL COMPLEMENT INHIBITION BASED ON URINARY UC5B-9 DETECTION"

GENEVA, Jan. 29 -- Q32 BIO INC. (830 Winter StreetWaltham, MA 02451) filed a patent application (PCT/US2024/038183) for "TARGETED TREATMENT OF COMPLEMENT-MEDIATED DISEASE THROUGH LOCAL COMPLEMENT INHIBITION BASED ON URINARY UC5B-9 DETECTION" on Jul 16, 2024. With publication no. WO/2025/019486, the details related to the patent application was published on Jan 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WAWERSIK, Stefan (c/o Q32 Bio Inc.830 Winter StreetWaltham, MA 02451), VIOLETTE, Shelia Marie (c/o Q32 Bio Inc.830 Winter StreetWaltham, MA 02451), MORGAN, Jennifer (c/o Q32 Bio Inc.8...